Skip to main content
Erschienen in: Acta Neuropathologica 2/2017

26.05.2017 | Correspondence

Synchronous gemistocytic astrocytoma IDH-mutant and oligodendroglioma IDH-mutant and 1p/19q-codeleted in a patient with CCDC26 polymorphism

verfasst von: Rachael A. Vaubel, Thomas M. Kollmeyer, Alissa A. Caron, Emily G. Barr Fritcher, Jesse S. Voss, Haohai Liang, Robert B. Jenkins, Caterina Giannini, Benjamin R. Kipp

Erschienen in: Acta Neuropathologica | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Excerpt

Multicentric low-grade gliomas are rare and their etiology is incompletely understood. We present the case of a 49-year-old man with new-onset seizures and two radiologically distinct masses involving the frontal lobes bilaterally (Fig. 1a–d, S1). Both masses were biopsied and demonstrated infiltrating gliomas with differing morphology (Fig. 1e–l). The right frontal mass was consistent with a gemistocytic astrocytoma. IDH1-R132H immunostain was positive, ATRX expression lost, and p53 expression low. In contrast, the left frontal mass demonstrated uniform small cells consistent with an oligodendroglioma. The tumor was positive for IDH1-R132H with retained ATRX expression.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Abou-El-Ardat K, Seifert M, Becker K, Eisenreich S, Lehmann M, Hackmann K et al (2017) Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas. Neuro Oncol. doi:10.1093/neuonc/now231 PubMedPubMedCentral Abou-El-Ardat K, Seifert M, Becker K, Eisenreich S, Lehmann M, Hackmann K et al (2017) Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas. Neuro Oncol. doi:10.​1093/​neuonc/​now231 PubMedPubMedCentral
2.
Zurück zum Zitat Cancer Genome Atlas Research N, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481–2498. doi:10.1056/NEJMoa1402121 CrossRef Cancer Genome Atlas Research N, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481–2498. doi:10.​1056/​NEJMoa1402121 CrossRef
3.
Zurück zum Zitat di Russo P, Perrini P, Pasqualetti F, Meola A, Vannozzi R (2013) Management and outcome of high-grade multicentric gliomas: a contemporary single-institution series and review of the literature. Acta Neurochir (Wien) 155:2245–2251. doi:10.1007/s00701-013-1892-9 CrossRef di Russo P, Perrini P, Pasqualetti F, Meola A, Vannozzi R (2013) Management and outcome of high-grade multicentric gliomas: a contemporary single-institution series and review of the literature. Acta Neurochir (Wien) 155:2245–2251. doi:10.​1007/​s00701-013-1892-9 CrossRef
5.
6.
Zurück zum Zitat Jenkins RB, Xiao Y, Sicotte H, Decker PA, Kollmeyer TM, Hansen HM et al (2012) A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation. Nat Genet 44:1122–1125. doi:10.1038/ng.2388 CrossRefPubMedPubMedCentral Jenkins RB, Xiao Y, Sicotte H, Decker PA, Kollmeyer TM, Hansen HM et al (2012) A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation. Nat Genet 44:1122–1125. doi:10.​1038/​ng.​2388 CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Sahm F, Korshunov A, Schrimpf D, Stichel D, Jones DT, Capper D et al (2017) Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas. Acta Neuropathol 133:325–327. doi:10.1007/s00401-016-1657-7 CrossRefPubMed Sahm F, Korshunov A, Schrimpf D, Stichel D, Jones DT, Capper D et al (2017) Gain of 12p encompassing CCND2 is associated with gemistocytic histology in IDH mutant astrocytomas. Acta Neuropathol 133:325–327. doi:10.​1007/​s00401-016-1657-7 CrossRefPubMed
9.
Zurück zum Zitat Vergani F, Sanson M, Duffau H (2009) Combined multiple surgical intervention and chemotherapy for multicentric WHO grade II glioma: a long-term follow-up study. Acta Neurochir (Wien) 151:1699–1704. doi:10.1007/s00701-009-0306-5 CrossRef Vergani F, Sanson M, Duffau H (2009) Combined multiple surgical intervention and chemotherapy for multicentric WHO grade II glioma: a long-term follow-up study. Acta Neurochir (Wien) 151:1699–1704. doi:10.​1007/​s00701-009-0306-5 CrossRef
10.
Zurück zum Zitat Weber RG, Sabel M, Reifenberger J, Sommer C, Oberstrass J, Reifenberger G et al (1996) Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene 13:983–994PubMed Weber RG, Sabel M, Reifenberger J, Sommer C, Oberstrass J, Reifenberger G et al (1996) Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene 13:983–994PubMed
Metadaten
Titel
Synchronous gemistocytic astrocytoma IDH-mutant and oligodendroglioma IDH-mutant and 1p/19q-codeleted in a patient with CCDC26 polymorphism
verfasst von
Rachael A. Vaubel
Thomas M. Kollmeyer
Alissa A. Caron
Emily G. Barr Fritcher
Jesse S. Voss
Haohai Liang
Robert B. Jenkins
Caterina Giannini
Benjamin R. Kipp
Publikationsdatum
26.05.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Acta Neuropathologica / Ausgabe 2/2017
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-017-1727-5

Weitere Artikel der Ausgabe 2/2017

Acta Neuropathologica 2/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.